+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Allergy Drugs Market Research Report by Type (Drug Allergy, Food Allergy, and Inhaled Allergy), Treatment, Distribution Channels, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 230 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5264366
UP TO OFF until Dec 31st 2022
The Global Allergy Drugs Market size was estimated at USD 25.35 billion in 2021, USD 27.43 billion in 2022, and is projected to grow at a CAGR 8.37% to reach USD 41.08 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Allergy Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
  • Based on Treatment, the market was studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs is further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy is further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
  • Based on Distribution Channels, the market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Allergy Drugs market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Drugs Market, including AbbVie Inc., Aimmune Therapeutics, Inc, ALK-Abelló A/S, Allergy Therapeutics, Amneal Pharmaceuticals PLC, Astra Biotech GmbH, AstraZeneca PLC, Aurobindo Pharma, Bayer AG, Cadila Healthcare Limited, Chongqing Huapont Pharmaceutical Co., Ltd, Cipla Inc, Dr. Reddy’s Laboratories Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, LETI Pharma GmBH, Lupin Limited, Magna Pharmaceuticals, Inc., Merck & Co., Inc, Mylan N.V, Novartis AG, Sanofi SA, Stallergenes Greer Ltd, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Allergy Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Drugs Market?
6. What is the market share of the leading vendors in the Global Allergy Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Allergy Drugs Market?
Frequently Asked Questions about the Global Allergy Drugs Market

What is the estimated value of the Global Allergy Drugs Market?

The Global Allergy Drugs Market was estimated to be valued at $25.35 Billion in 2021.

What is the growth rate of the Global Allergy Drugs Market?

The growth rate of the Global Allergy Drugs Market is 8.3%, with an estimated value of $41.08 Billion by 2027.

What is the forecasted size of the Global Allergy Drugs Market?

The Global Allergy Drugs Market is estimated to be worth $41.08 Billion by 2027.

Who are the key companies in the Global Allergy Drugs Market?

Key companies in the Global Allergy Drugs Market include AbbVie Inc., Aimmune Therapeutics, Inc, ALK, Abelló A/S, Allergy Therapeutics, Amneal Pharmaceuticals PLC, Astra Biotech GmbH, AstraZeneca PLC and Bayer AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of allergy globally
5.1.1.2. Increasing development of allergy-specific drugs
5.1.1.3. Changing lifestyle with increasing tobacco consumption
5.1.2. Restraints
5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
5.1.3. Opportunities
5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
5.1.3.2. Rising consumer awareness on food allergies
5.1.4. Challenges
5.1.4.1. Availability of alternative drugs for allergy
5.2. Cumulative Impact of COVID-19
6. Allergy Drugs Market, by Type
6.1. Introduction
6.2. Drug Allergy
6.3. Food Allergy
6.4. Inhaled Allergy
7. Allergy Drugs Market, by Treatment
7.1. Introduction
7.2. Anti-allergy Drugs
7.2.1. Antihistamines
7.2.2. Corticosteroids
7.2.3. Leukotriene Inhibitors
7.3. Immunotherapy
7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)
8. Allergy Drugs Market, by Distribution Channels
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies & Drug Stores
9. Americas Allergy Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Allergy Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Allergy Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AbbVie Inc.
13.2. Aimmune Therapeutics, Inc
13.3. ALK-Abelló A/S
13.4. Allergy Therapeutics
13.5. Amneal Pharmaceuticals PLC
13.6. Astra Biotech GmbH
13.7. AstraZeneca PLC
13.8. Aurobindo Pharma
13.9. Bayer AG
13.10. Cadila Healthcare Limited
13.11. Chongqing Huapont Pharmaceutical Co., Ltd
13.12. Cipla Inc
13.13. Dr. Reddy’s Laboratories Ltd
13.14. F. Hoffmann-La Roche AG
13.15. GlaxoSmithKline PLC
13.16. HAL Allergy B.V.
13.17. Hikma Pharmaceuticals PLC
13.18. Johnson & Johnson Services, Inc
13.19. LETI Pharma GmBH
13.20. Lupin Limited
13.21. Magna Pharmaceuticals, Inc.
13.22. Merck & Co., Inc
13.23. Mylan N.V
13.24. Novartis AG
13.25. Sanofi SA
13.26. Stallergenes Greer Ltd
13.27. Sun Pharmaceutical Industries Ltd
13.28. Teva Pharmaceutical Industries Ltd
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ALLERGY DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY DRUGS MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL ALLERGY DRUGS MARKET DYNAMICS
FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2027
FIGURE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2021 VS 2027 (%)
FIGURE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2021 VS 2027 (USD BILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2027
FIGURE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2021 VS 2027 (%)
FIGURE 33. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2021 VS 2027 (USD BILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2027
FIGURE 35. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 36. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 37. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 38. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2019-2027 (USD BILLION)
FIGURE 40. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 41. AMERICAS ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 43. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 45. ARGENTINA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. BRAZIL ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. CANADA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. MEXICO ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. UNITED STATES ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 51. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2027
FIGURE 53. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 55. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 57. AUSTRALIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. CHINA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. INDIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. INDONESIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. JAPAN ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. MALAYSIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. PHILIPPINES ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. SINGAPORE ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. TAIWAN ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. THAILAND ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 71. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 72. FRANCE ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. GERMANY ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. ITALY ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. NETHERLANDS ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. QATAR ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. RUSSIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 79. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 80. SPAIN ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 81. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. GLOBAL ALLERGY DRUGS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 84. GLOBAL ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY DRUGS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ALLERGY DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 17. AMERICAS ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 19. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 22. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 23. AMERICAS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 25. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 28. AMERICAS ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 30. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2019-2027 (USD BILLION)
TABLE 33. AMERICAS ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY STATE, 2019-2027 (USD BILLION)
TABLE 35. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY REGION, 2019-2027 (USD BILLION)
TABLE 38. AMERICAS ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY STATE, 2019-2027 (USD BILLION)
TABLE 40. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 43. AMERICAS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 45. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY REGION, 2019-2027 (USD BILLION)
TABLE 48. AMERICAS ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY STATE, 2019-2027 (USD BILLION)
TABLE 50. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 53. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 54. AMERICAS ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 56. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 59. AMERICAS ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 61. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2019-2027 (USD BILLION)
TABLE 64. AMERICAS ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY STATE, 2019-2027 (USD BILLION)
TABLE 66. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 68. AMERICAS ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 71. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 72. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 73. ARGENTINA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 75. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 76. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 77. BRAZIL ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 79. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 80. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 81. CANADA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 83. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 84. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 85. MEXICO ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 87. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 88. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 89. UNITED STATES ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 91. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 92. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 93. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 94. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 96. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 97. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 98. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 99. AUSTRALIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 101. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 102. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 103. CHINA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 105. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 106. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 107. INDIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 108. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 109. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 110. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 111. INDONESIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 112. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 113. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 114. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 115. JAPAN ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 117. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 118. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 119. MALAYSIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 120. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 121. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 122. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 123. PHILIPPINES ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 124. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 125. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 126. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 127. SINGAPORE ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 128. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 129. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 130. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 131. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 132. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 133. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 134. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 135. TAIWAN ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 136. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 137. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 138. TAIWAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 139. THAILAND ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 140. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 141. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 142. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 148. FRANCE ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 149. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 150. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 151. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 152. GERMANY ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 153. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 154. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 155. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 156. ITALY ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 157. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 158. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 159. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 160. NETHERLANDS ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 161. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 162. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 163. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 164. QATAR ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 165. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 166. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 167. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 168. RUSSIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 169. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 170. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 171. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 172. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 173. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 174. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 175. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 176. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 177. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 178. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 179. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 180. SPAIN ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 181. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 182. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 183. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 184. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 185. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 186. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 187. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 188. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 189. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 190. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2019-2027 (USD BILLION)
TABLE 191. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 192. GLOBAL ALLERGY DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 193. GLOBAL ALLERGY DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 194. GLOBAL ALLERGY DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 195. GLOBAL ALLERGY DRUGS MARKET RANKING
TABLE 196. GLOBAL ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 197. GLOBAL ALLERGY DRUGS MARKET MERGER & ACQUISITION
TABLE 198. GLOBAL ALLERGY DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 199. GLOBAL ALLERGY DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 200. GLOBAL ALLERGY DRUGS MARKET INVESTMENT & FUNDING
TABLE 201. GLOBAL ALLERGY DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 202. GLOBAL ALLERGY DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Aimmune Therapeutics, Inc
  • ALK-Abelló A/S
  • Allergy Therapeutics
  • Amneal Pharmaceuticals PLC
  • Astra Biotech GmbH
  • AstraZeneca PLC
  • Aurobindo Pharma
  • Bayer AG
  • Cadila Healthcare Limited
  • Chongqing Huapont Pharmaceutical Co., Ltd
  • Cipla Inc
  • Dr. Reddy’s Laboratories Ltd
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • HAL Allergy B.V.
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc
  • LETI Pharma GmBH
  • Lupin Limited
  • Magna Pharmaceuticals, Inc.
  • Merck & Co., Inc
  • Mylan N.V
  • Novartis AG
  • Sanofi SA
  • Stallergenes Greer Ltd
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd

Methodology

Loading
LOADING...